milestones
Founded 2020
Partnered 2021
Team
Nicole Paulk
Board
LEAD INVESTOR
category
Oncology
Immunology
Combining the promise of two transformative therapeutic technologies, AAV gene therapy and cytokine immunotherapy, into a single, powerful new treatment modality to fight cancer
No items found.
